Investigators from Mass General determined that the BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.
News from the Department of Medicine
Microbial Bile Acid Metabolism Regulates Gut Barrier Integrity and Liver Injury and Could Be a New Treatment Target
Researchers looked at the impact of bacterial metabolism of host-produced bile acid (BA) metabolites on epithelial barrier integrity.
This is the first work to show that active depletion rather than supplementation of vitamins provides a health benefit to the animal.
A recent clinical trial led by a team at Massachusetts General Hospital (MGH) indicates that Fitbit wearable devices can help spot undiagnosed atrial fibrillation and therefore identify patients who would benefit from stroke prevention therapies.
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
When patients with lupus received lower dosing of hydroxychloroquine—in accordance with current ophthalmology guidelines—they had a higher risk of lupus flares than when they were taking a higher dose of the medication.
In a recent study in Science Advances, the team, which was led by Ken Hiratsuka, MD, PhD, and Ryuji Morizane, MD, PhD, reports using the new modeling system to identify two potential therapeutics for APRKD, which currently has no FDA-approved treatment.
In this nationally representative race- and sex-specific cross-sectional study of US adults, gout was more prevalent in adults self-reporting Black race during a recent 10-year period compared with their White counterparts.
Chronic use of e-cigarettes, commonly known as vaping, can result in progressive small airway obstruction and asthma-like symptoms such as shortness of breath and chest pains, according to researchers at Massachusetts General Hospital (MGH).
The researchers found that 12.5% of placebo-treated individuals and 1% of BCG-treated individuals met criteria for confirmed COVID-19, yielding a vaccine effectiveness of 92%.
Fellowships, Residencies & Other Opportunities
Mass General offers specialized residencies and fellowships in each of our multidisciplinary care centers and clinical departments, as well as observerships, clerkships and continuing medical education.